| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/20/2011 | EP2344533A2 Tmprss4-specific human antibody |
| 07/20/2011 | EP2344532A1 Purification process for fragment antibodies |
| 07/20/2011 | EP2344525A1 Epitopes derived from satb2 and uses thereof |
| 07/20/2011 | EP2344523A1 Combination gas vaccines and therapeutics |
| 07/20/2011 | EP2344194A2 Pcsk9 antagonists |
| 07/20/2011 | EP2344190A2 New virulence factors of streptococcus pneumoniae |
| 07/20/2011 | EP2344180A2 Methods for predicting production of activating signals by cross-linked binding proteins |
| 07/20/2011 | EP2344177A1 Immunotherapy compositions for the treatment and prevention of amyloidosis |
| 07/20/2011 | EP2021799B1 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
| 07/20/2011 | EP1997511B1 Therapeutic agent for rheumatoid arthritis |
| 07/20/2011 | EP1880219B1 Gpr18 as a biomaker for th1 mediated immune response |
| 07/20/2011 | EP1712564B1 Anti-nc1 monoclonal antibody |
| 07/20/2011 | EP1684869B1 Methods of therapy for b cell-related cancers |
| 07/20/2011 | EP1625164B1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 42-46 |
| 07/20/2011 | EP1552300B1 Sets of digital antibodies directed against short epitopes, and methods using same |
| 07/20/2011 | EP1545613B1 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 07/20/2011 | EP1373477B1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 07/20/2011 | EP1181317B1 An integrin heterodimer and an alpha subunit thereof |
| 07/20/2011 | EP1157043B1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 07/20/2011 | EP1053256B1 Antibodies to death receptor 4 (dr4) and uses thereof |
| 07/20/2011 | CN102131829A Antibodies against human epo receptor |
| 07/20/2011 | CN102131828A Antibodies to human programmed death receptor pd-1 |
| 07/20/2011 | CN102131827A Compositions for pulmonary delivery of premedication |
| 07/20/2011 | CN102131519A Diagnostic antibody assay |
| 07/20/2011 | CN102127523A Hybridoma cell line and application thereof |
| 07/20/2011 | CN102127168A Recombinant fusion protein of triggering receptor-1 expressed on myeloid cells (TREM-1) and application thereof |
| 07/20/2011 | CN102127167A Whole human TNF alpha (tumor necrosis factor alpha) monoclonal antibody and preparation and application thereof |
| 07/20/2011 | CN102127163A Cloning, protein expression, polyclonal antibody preparation and use of nuclear factor TDRP1 |
| 07/20/2011 | CN102127150A Nestin portion polypeptide and application thereof |
| 07/20/2011 | CN102127149A Myocardial specificity homeobox part polypeptide and application thereof |
| 07/20/2011 | CN102127148A Polypeptide in cluster-of-differentiation part on surface of vascular endothelial cell and use thereof |
| 07/20/2011 | CN102127143A Preparation method of alpha-glucan antigen and specificity monoclonal antibody |
| 07/20/2011 | CN101445558B Monoclonal antibody of glycinin and application thereof |
| 07/20/2011 | CN101402671B Method simultaneously separating fibrinogen and immunoglobulin from livestock and poultry blood |
| 07/20/2011 | CN101245106B Anti-VRGF acceptor monoclone antibody, preparation method and application thereof |
| 07/20/2011 | CN101113177B Method for separating and purifying anti-hepatitis B immune globulin from plasma or plasma component |
| 07/20/2011 | CN101065402B Process for obtaining antibodies |
| 07/19/2011 | US7982024 Antibodies to insulin-like growth factor I receptor |
| 07/19/2011 | US7982017 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same |
| 07/19/2011 | US7982016 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2011 | US7982013 Frizzled-binding agents and uses thereof |
| 07/19/2011 | US7982012 Compositions and methods for the therapy and diagnosis of cytomegalovirus |
| 07/19/2011 | US7982011 Mutated anti-cd22 antibodies and immunoconjugates |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981997 Growth factor which acts through ErbB-4 RTK |
| 07/19/2011 | US7981865 Antigenic fragments of human factor VIII polypeptides |
| 07/19/2011 | US7981843 Antibody specificity transfer using minimal essential binding determinants |
| 07/19/2011 | US7981693 Combined measurement of anti-CCP and serum amyloid A to assess rheumatoid arthritis |
| 07/19/2011 | US7981672 Monoclonal antibody and use thereof |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981623 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 07/19/2011 | US7981620 Artificial antibody polypeptides |
| 07/19/2011 | US7981615 Compositions and methods for treating diseases associated with T-box and N-Myc |
| 07/19/2011 | US7981614 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/19/2011 | US7981598 Preventive/remedy for respiratory diseases |
| 07/19/2011 | US7981434 Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis |
| 07/19/2011 | US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 07/19/2011 | US7981425 Thrombopoietic compounds |
| 07/19/2011 | US7981422 Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof |
| 07/19/2011 | US7981421 Combinations of antibodies selective for DR5 and other therapeutic agents |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | US7981416 Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency |
| 07/19/2011 | US7981414 Anti-inflammatory dAb |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | US7981410 Using immunoglobulin specific to viral transport protein associated with budding to prevent and treat viral diseases |
| 07/19/2011 | CA2599914C Lectin isolated from bryopsis maxima that binds high-mannose-type sugar chains, used to purify chicken antibodies |
| 07/19/2011 | CA2477232C Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 07/19/2011 | CA2433501C Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/14/2011 | WO2011085343A1 Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies |
| 07/14/2011 | WO2011085165A2 Ca-125 immune complexes as biomarkers of ovarian cancer |
| 07/14/2011 | WO2011085103A2 Plasma kallikrein binding proteins |
| 07/14/2011 | WO2011085057A2 Methods for detecting insulin autoantibody |
| 07/14/2011 | WO2011084882A2 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria |
| 07/14/2011 | WO2011084750A1 Antibody formulation |
| 07/14/2011 | WO2011084496A1 Anti-her2 antibodies and their uses |
| 07/14/2011 | WO2011084357A1 Modulation of pilr to treat immune disorders |
| 07/14/2011 | WO2011084255A2 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants |
| 07/14/2011 | WO2011083637A1 Therapeutic agent for hepatic disorder |
| 07/14/2011 | WO2011083175A1 Monoclonal antibody anti-tumor necrosis factor (tnf), which defines sequences, compositions comprising it and its applications |
| 07/14/2011 | WO2011083141A2 Method for generation of immunoglobulin sequences by using lipoprotein particles |
| 07/14/2011 | WO2011083140A1 Immunoglobulin single variable domain directed against human cxcr4 |
| 07/14/2011 | WO2011083124A1 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 07/14/2011 | WO2011083091A2 Methods for treating pancreatic cancer |
| 07/14/2011 | WO2011083088A2 Methods for treating colorectal cancer |
| 07/14/2011 | WO2011083080A1 Modified food grade microorganism for treatment of inflammatory bowel disease |
| 07/14/2011 | WO2011061700A3 Ifnϒ inhibitors in the treatment of motoneuron diseases |
| 07/14/2011 | WO2011038290A3 Neutralizing antibodies to hiv-1 and their use |
| 07/14/2011 | WO2011028697A3 Uses of cd 116 expression level |
| 07/14/2011 | WO2011025883A3 Natural igm antibodies |
| 07/14/2011 | WO2010113117A3 Preparation of isolated agonist anti-edar monoclonal antibodies |
| 07/14/2011 | US20110173727 Endophyte Enhanced Seedlings with Increased Pest Tolerance |
| 07/14/2011 | US20110172406 Molecular structure of rhd negative |
| 07/14/2011 | US20110172400 Compositions monovalent for cd40l binding and methods of use |
| 07/14/2011 | US20110172399 Il-21 antagonists |
| 07/14/2011 | US20110172398 Bispecific binding molecules for anti-angiogenesis therapy |
| 07/14/2011 | US20110172397 Anti-psgl-1 antibodies |